European Journal of Clinical Pharmacology 2008-01-01

Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.

Mária Tóth, Sándor Drabant, Bálint Varga, Gyula Végso, Anna Cseh, Imre Szentpéteri, Imre Klebovich

Index: Eur. J. Clin. Pharmacol. 64(1) , 93-4, (2008)

Full Text: HTML

Abstract


Related Compounds

Related Articles:

The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosis.

2010-11-01

[J. Neural Transm. Gen. Sect. 117(11) , 1319-25, (2010)]

[Pineal hormone melatonin in low doses potentiates psychotropic and chronotropic activity of tofisopam in rats].

2013-01-01

[Eksp. Klin. Farmakol. 76(4) , 15-7, (2013)]

Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.

2008-01-15

[Aliment. Pharmacol. Ther. 27(2) , 197-206, (2008)]

Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling.

2007-05-15

[Toxicol. Appl. Pharmacol. 221(1) , 111-8, (2007)]

Method validation and determination of enantiomers and conformers in tofisopam drug substances and drug products by chiral high-performance liquid chromatography and kinetic and thermodynamic study of the interconversion of the conformers.

2006-09-29

[J. Chromatogr. A. 1129(1) , 47-53, (2006)]

More Articles...